Sugar-modified cytostatics

US6271342A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Hans-Georg Lerchen · Leverkusen, DE
• Karsten von dem Bruch · Leverkusen, DE
• Uwe Petersen · Leverkusen, DE
• Jorg Baumgarten · Wuppertal, DE
• Norbert Piel · Erkrath, DE
• Horst-Peter Antonicek · Bensberg, DE
• Walter Weichel · Cologne, DE
• Michael Sperzel · Wuppertal, DE
• Klaus-Dieter Bremm · Recklinghausen, DE

Key dates

• Filing date: Sep 25, 1997
• Grant date: Aug 7, 2001
• Expiry date: Sep 25, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to cytostatics which, by modification with sugar, are tumor-specific. Suitable spacers ensure serum stability and at the same time an intracellular action.